Alumni Ventures Group
Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, with offices across North America. It provides access to venture investing for individual accredited investors, particularly alumni networks, by offering diversified portfolios of venture opportunities and allowing members to invest alongside fellow alumni in ventures led by peers. The firm backs early-stage and later-stage opportunities across technology, consumer, healthcare, financial services, and other sectors, with a sector- and geography-agnostic approach. It typically invests between $10,000 and $3 million per deal and emphasizes the involvement of alumni connections and an institutional lead investor in opportunities. Alumni Ventures also offers focused funds to broaden participation, enabling accredited investors to access venture portfolios diversified by type, sector, stage, and geography. The model aims to democratize access to venture capital while maintaining rigorous selection standards through alumni networks.
Top Stages
Past deals in Healthcare
Salvo Health
Seed Round in 2025
Salvo Health is a specialty care provider operating an app-based virtual clinic focused on managing chronic gut conditions. The company improves access to advanced healthcare by employing its proprietary Whole Self Science model, which considers overall health and contributing factors beyond the gut to pinpoint underlying causes and offer individualized, ongoing treatment strategies for patients with chronic gastrointestinal issues.
Aescape
Venture Round in 2025
Founded in 2017, Aescape is a New York-based technology company specializing in data-driven massage therapy and wellness experiences. It offers a holistic approach to physical wellness and recovery, serving both elite athletes and fitness beginners. The company combines cutting-edge research with user-friendly interfaces and insights-driven methods to enhance overall well-being.
Helper Bees
Series C in 2025
Founded in 2015, Helper Bees operates a platform connecting seniors with local helpers for various home care services in the United States. It partners with insurance carriers to enhance home care experiences through digitization, intelligent care sourcing, and machine learning-driven analytics.
Springbok Analytics
Series A in 2025
Springbok Analytics offers an AI-powered software platform that transforms MRIs into three-dimensional analyses of muscle to enable true precision. Springbok Analytics' advanced imaging technology identifies and measures each individual muscle, providing data to scientists, physical therapists, athletic trainers, and physicians to evaluate muscle function in relation to performance and injury management. The technology has numerous applications, including injury management, performance enhancement, and the treatment of musculoskeletal conditions.
Torch Dental
Venture Round in 2025
Torch Dental offers an all-in-one digital platform for dental practices to manage supply ordering and inventory efficiently. It simplifies the ordering process, allowing dentists to focus more on patient care.
Precision Neuroscience
Series C in 2024
Precision Neuroscience is a New York-based neurotechnology company developing a next-generation brain–computer interface platform to enable breakthrough treatments for neurological illnesses affecting billions worldwide. The company aims to deliver minimally invasive, safely removable implants capable of processing large amounts of neural data across multiple brain regions to support therapeutic interventions. Founded in 2021, it focuses on translating neural signals into clinical outcomes, with technology described as a thin-film microelectrode array that conforms to the brain surface without penetrating tissue, enabling broad neural data collection to aid treatment of spinal cord injuries, stroke, and neurodegenerative diseases.
Lōvu
Pre Seed Round in 2024
Lōvu Health is a digital health company specializing in maternal care. It provides a platform that supports mothers and babies from conception through to postpartum, using AI to deliver real-time analytics and evidence-based insights. The platform monitors vital signs like fetal heart rate and blood pressure, offers personalized recommendations, and sends action-oriented alerts, empowering users with reliable information and expert knowledge.
Canid
Series A in 2024
Canid is a healthcare technology company that focuses on pediatric vaccination workflows. It provides a healthcare dashboard and process tool to simplify vaccination record management, automate vaccine workflow, and oversee vaccine inventory. The platform includes a scanning system that eliminates manual data entry by capturing vaccine information and uploading it to state immunization registries, reducing administrative tasks for pediatric practitioners. It also offers administrative consulting and helps secure vaccine margins, supporting efficient practice operations for clinicians while giving state officials clearer oversight of vaccination programs.
Andromeda Surgical
Seed Round in 2024
Andromeda Surgical develops autonomous robotic systems aimed at enhancing surgical precision, consistency, and efficiency.
CytoVale
Series D in 2024
CytoVale is a medical technology company based in San Francisco that develops biomarkers derived from the mechanical properties of single cells. The company uses microfluidics to route and probe cells, enabling the measurement of multiple biophysical indicators at once. Its technology aims to advance early detection of immune-mediated diseases and sepsis through the analysis of cell mechanics and machine learning. By translating biophysical signals into diagnostic information, CytoVale seeks to improve diagnostic accuracy, support timely treatment decisions, and reduce healthcare costs.
Beam
Venture Round in 2024
Beam Technologies Inc., founded in 2012 and based in Columbus, Ohio, operates as a dental benefits company with a focus on digital-first solutions. The company designs and develops the Beam Brush, a wirelessly connected toothbrush that allows users to track and monitor their brushing habits through a smartphone app. In addition to this innovative product, Beam offers dental insurance plans that include perks such as floss, toothpaste, and the Beam Brush itself. The company's approach emphasizes ease-of-use and tailored pricing, with a strong emphasis on preventive care and rewards for good dental hygiene.
Centaur Labs
Series B in 2024
Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.
Bionic Health
Seed Round in 2024
Bionic Health specializes in digital healthcare, focusing on preventative health services for individuals with chronic pain. The company's platform offers frequent diagnostics and employs machine learning to create customized treatment plans, aiming to slow down aging and provide personalized insights for patients.
AminoChain
Seed Round in 2024
AminoChain provides a platform that connects data from healthcare organizations to support biosample handling. It enables users to manage biosample inventories, maintain asset ownership, and collaborate with partners through an integrated workflow for procurement, agreements, and payments. The company also applies blockchain-based tokenization to stem cell donations, incentivizing donors and enabling biobanks to securely manage inventory and donor records.
Syntra
Pre Seed Round in 2024
Syntra develops an EHR platform that streamlines billing, records, and follow-ups, helping doctors automate tasks.
GC Therapeutics
Series A in 2024
GC Therapeutics employs synthetic biology to transform patient-derived stem cells into diverse cell types efficiently and at scale. The company has validated its technology across multiple applications, creating SuperCells™ tailored for specific conditions. Originally developed in Professor George Church's lab at Harvard Medical School, GC Therapeutics is dedicated to bringing this innovative method to patients.
Kindbridge Behavioral Health
Pre Seed Round in 2024
Kindbridge Behavioral Health provides individual therapy, family therapy, group services, pricing, and insurance services. They provide treatments for depression, anxiety, gaming, stress, relationships, PTSD, family conflicts, mood disorders, gambling, trauma, addiction, dissociative disorders, and ADHD.
Clarium Health
Venture Round in 2024
Clarium Health is a developer of an artificial intelligence-based platform aimed at enhancing healthcare operations. The company's innovative platform automates various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to accurately predict demand, allowing hospitals and healthcare centers to optimize staffing and inventory management. This capability helps prevent shortages and stockouts, reduces supplier lead times, and identifies alternative products when necessary. By empowering healthcare providers with intelligent workflow automation and actionable insights, Clarium Health is transforming the efficiency and effectiveness of healthcare delivery.
MD Ally
Series A in 2024
MD Ally develops a telehealth platform that integrates into emergency medical dispatch processes. It connects non-emergency callers to virtual healthcare professionals for triage, follow-up care, and social services, freeing up resources for true emergencies.
InGel Therapeutics
Seed Round in 2024
InGel Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. The company focuses on developing engineered cell therapies aimed at targeting neuroprotective pathways to address retinal degeneration. Utilizing stem cells and their secretome, InGel Therapeutics aims to provide neuroprotection for blinding diseases such as retinitis pigmentosa and macular degeneration. The company leverages biodegradable polymers to isolate neuroprotective proteins, initially testing these solutions in vitro before advancing to in vivo applications. Through its innovative approach, InGel Therapeutics seeks to enable healthcare professionals to more effectively treat patients suffering from retinal degeneration.
Hopscotch Primary Care
Series C in 2024
Hopscotch Primary Care is a healthcare company focused on transforming rural healthcare through data-driven, team-based care that expands access and improves quality for patients in rural communities. The organization delivers tailored quality care via a collaborative model and provides resources and support for patients inside and outside clinics, enabling clinicians to offer the right care and continuity of service.
Grayce
Series A in 2024
Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized guidance and support for families caring for aging adults and children. Founded in 2019, the company offers a range of services designed to assist caregivers with various aspects of care, including insurance, finances, legal plans, medical care, home care, housing, daily needs, and overall well-being. Each member of Grayce receives dedicated support from a social worker who helps manage their comprehensive care needs by planning, prioritizing, identifying resources, coordinating care, and advocating on their behalf. Through its social care management platform, Grayce empowers family caregivers to navigate the complexities of caring for vulnerable loved ones.
Nanochon
Seed Round in 2024
Nanochon is developing an implantable, 3D-printed cartilage implant designed to replace damaged cartilage and promote new tissue growth in joints, with a focus on knee damage. The device combines 3D printing and a novel nanomaterial to enable on-demand, cost-effective solutions intended to restore joint function and improve outcomes for young and active patients.
Clarity Pediatrics
Seed Round in 2024
Clarity Pediatrics is a healthcare company focused on transforming pediatric chronic care, specifically for children diagnosed with ADHD. With nearly 10% of American children affected by this condition, the company aims to alleviate the challenges parents face in accessing appropriate care. Clarity Pediatrics has developed a virtual pediatric ADHD clinic that leverages a tech-enabled clinical model, offering features such as video conferencing, secure messaging, and electronic health records. This innovative approach is designed to deliver high-quality, evidence-based care to families, regardless of their location or insurance status. Through its platform, Clarity Pediatrics strives to achieve exceptional health outcomes that can significantly improve the developmental trajectory of affected children.
Nectero Medical
Series D in 2024
Nectero Medical is a clinical-stage biotechnology company based in Dover, Delaware, founded in 2017. The company is focused on developing a novel treatment aimed at stabilizing the growth of mid-sized abdominal aortic aneurysms and preventing their rupture. Nectero Medical's innovative approach involves delivering a compound with a stabilizing agent directly to the aneurysm site, which inhibits further breakdown of the vessel wall and strengthens it. This treatment enables patients to undergo earlier intervention safely, potentially delaying or eliminating the need for major endovascular or surgical repairs.
HelixNano
Series A in 2024
HelixNano is a biotechnology startup that employs artificial intelligence and synthetic biology to develop innovative treatments for genetic diseases. Founded with backing from Y Combinator and venture capitalists, the company initially focused on creating cancer vaccines over two years. Currently, HelixNano is adapting its technology to combat COVID-19, aiming to produce precise and safe vaccine candidates. Its long-term goal is to develop a universal coronavirus vaccine that protects against future outbreaks.
Century Health
Pre Seed Round in 2024
Century Health is a healthcare technology company that enhances drug development and commercialization by utilizing artificial intelligence to harness otherwise inaccessible longitudinal clinical data. Its innovative platform connects with real-world, disease-specific datasets and employs AI to clean and standardize this information. This process eliminates data silos, allowing researchers to analyze real-world data more effectively and efficiently. By streamlining access to critical insights, Century Health aims to accelerate the pace of drug commercialization while upholding patient privacy and supporting the broader research community.
Torch Dental
Venture Round in 2024
Torch Dental offers an all-in-one digital platform for dental practices to manage supply ordering and inventory efficiently. It simplifies the ordering process, allowing dentists to focus more on patient care.
Pi Health
Series A in 2024
Pi Health is a technology company specializing in streamlining oncology clinical trials. It offers a global, secure, and compliant platform that integrates various systems, enabling life sciences companies to identify suitable trial sites, manage them efficiently, and accelerate the development of lifesaving medicines. This, in turn, enhances patient access to cancer care and research, and facilitates the inclusion of diverse patient populations in clinical trials.
Nest Health
Seed Round in 2024
Nest Health is a family healthcare platform that brings medical services to the home through in-home and virtual visits. It serves patients across newborns, children, teens, and adults with a wide range of services including medical, behavioral health, and nutrition support, as well as preventive care, sick visits, and chronic disease management. The company aims to reduce the burden of arranging care by enabling patients to receive necessary treatments and consultations without leaving home, delivering convenient and accessible care in the familiar setting of the home.
BE Therapeutics
Seed Round in 2024
BE Therapeutics is a biotechnology company specializing in regenerative medicine. It develops innovative therapies aimed at repairing and restoring damaged brain and spinal cord tissue, with the goal of improving patient outcomes for neurological conditions and spinal cord injuries. The company's approach involves engineering functional tissue to replace or repair damaged structures, offering a novel solution in healthcare.
Pendulum Therapeutics
Series C in 2024
Pendulum Therapeutics is a biotechnology company specializing in microbiome-targeted therapies. Founded in 2013 by experts in microbiology, biochemistry, computational science, and clinical research, the company develops evidence-based medical probiotics to manage chronic illnesses, with a focus on type 2 diabetes. Its flagship product, Pendulum Glucose Control, has demonstrated efficacy in lowering blood sugar spikes and reducing A1C levels in clinical trials.
Alvee
Seed Round in 2024
Alvee offers an AI-driven tool for healthcare providers and payers. It assesses patients' health equity status by considering social determinants of health, chronic conditions, demographics, and health inequity risks. This enables better patient care and helps meet data stratification quality reporting requirements.
Piction Health
Seed Round in 2024
Piction Health is a company focused on enhancing access to dermatology care for patients experiencing skin, hair, or nail issues. The company offers a dermatology care application that allows patients to receive expert consultations from dermatologists within two days, including a diagnosis and personalized care plan. By leveraging artificial intelligence, Piction Health streamlines the diagnostic process for both patients and primary care providers, enabling quicker assessments of complex skin conditions. The application provides immediate second opinions, allowing primary care providers to efficiently address challenging skin diseases, thereby saving time and reducing costs associated with unnecessary repeat visits and ineffective treatments. Piction Health aims to ensure that high-quality dermatological care is accessible from the comfort of home, ultimately improving patient outcomes.
Arise
Seed Round in 2024
Arise is a provider of virtual care services focused on supporting individuals with eating disorders, a condition that affects a diverse range of people, yet often goes untreated. The company seeks to address the barriers and stigma associated with these disorders by expanding access to inclusive care through its innovative platform. This platform offers virtual therapy sessions with licensed therapists and dietitians, as well as support from care advocates who assist users in managing daily challenges. By fostering a community and providing ongoing support, Arise aims to deliver a new approach to healing that prioritizes both physical and mental health for those struggling with eating disorders.
Earli
Series A in 2024
Earli is a biotechnology company focused on advancing cancer detection and treatment through innovative technology. The company specializes in developing devices that utilize a novel gene therapy approach known as Synthetic Biopsy. This method compels cancer cells to produce synthetic biomarkers, which are not naturally occurring in the human body. These biomarkers can then be detected in bodily fluids such as blood, urine, or breath, allowing for early identification of cancer. By facilitating the early detection of homogeneous tumors, Earli aims to significantly improve the chances of successful treatment and personalize therapy options for patients. Additionally, the technology is designed to be visible during imaging procedures such as PET scans, enhancing the monitoring of cancer progression and treatment efficacy.
Featureform
Seed Round in 2023
Featureform is a company that specializes in developing machine learning tools tailored for the pharmaceutical and biotechnology sectors. It offers an open-source virtual feature store that enables data scientists to define, manage, and serve machine learning features throughout their organizations. The platform provides a unified interface to connect, transform, and join both streaming and batch data, facilitating the discovery and integration of features created by various teams. This functionality allows organizations to share features and enhance their machine learning models. Additionally, Featureform monitors and analyzes these features, offering the capability to freeze them, which allows teams to concentrate on building models that support efficient data pipelines.
Radix Health
Pre Seed Round in 2023
Radix Health is a platform that integrates the healthcare industry with market-based pricing, utilizing software and data engineering.
Clarium Health
Seed Round in 2023
Clarium Health is a developer of an artificial intelligence-based platform aimed at enhancing healthcare operations. The company's innovative platform automates various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to accurately predict demand, allowing hospitals and healthcare centers to optimize staffing and inventory management. This capability helps prevent shortages and stockouts, reduces supplier lead times, and identifies alternative products when necessary. By empowering healthcare providers with intelligent workflow automation and actionable insights, Clarium Health is transforming the efficiency and effectiveness of healthcare delivery.
DocStation
Seed Round in 2023
DocStation, Inc. is a cloud-based patient care platform headquartered in Austin, Texas, that was established in 2017. The company focuses on connecting payers and pharmacists to facilitate value-based care programs, which aim to reduce healthcare costs and enhance patient outcomes. Its platform equips pharmacists with essential tools, including a comprehensive dashboard that consolidates patient information such as diagnoses, medications, immunizations, allergies, and adverse events. This integration allows pharmacists to create care plans, set goals, monitor patient adherence, and schedule follow-ups, thereby enabling real-time connections with patients. With over 500 providers collaborating with innovative health plans on the platform, DocStation is positioned to transform the pharmacy landscape by aligning the interests of all stakeholders involved in patient care.
CytoVale
Series C in 2023
CytoVale is a medical technology company based in San Francisco that develops biomarkers derived from the mechanical properties of single cells. The company uses microfluidics to route and probe cells, enabling the measurement of multiple biophysical indicators at once. Its technology aims to advance early detection of immune-mediated diseases and sepsis through the analysis of cell mechanics and machine learning. By translating biophysical signals into diagnostic information, CytoVale seeks to improve diagnostic accuracy, support timely treatment decisions, and reduce healthcare costs.
Jona
Seed Round in 2023
Jona is a tech startup utilizing artificial intelligence to explore the connection between the microbiome and health. Its platform interprets microbiome tests, providing insights into bacteria, fungi, viruses, and protists, along with associated health conditions, symptoms, food sensitivities, and recommended actions for diet, exercise, sleep, and treatments.
Emm
Seed Round in 2023
Emm is a company focused on consumer health technology, developing tools to help individuals manage their health on their terms. It is building a menstrual cup with integrated biosensors designed to track biometric data and deliver personalized insights about menstrual health. The device aims to redefine period experiences by providing actionable information that helps users understand their health through technology and expert knowledge.
Forta
Series A in 2023
Forta provides healthcare services for children, specializing in autism support through applied behavior analysis therapy delivered via online training programs. It operates a telehealth platform offering AI-driven interventions and a personalized care approach that enables parents and caregivers to access structured guidance, expert support, and adaptive treatment plans designed to promote skill building and behavioral improvement.
Ellipsis Health
Series A in 2023
Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.
Eigen Therapeutics
Seed Round in 2023
Eigen Therapeutics is a biotechnology company dedicated to advancing cancer treatment through the development of innovative therapies. It specializes in "priming" therapies that enhance the effectiveness of targeted treatments by addressing cancer heterogeneity, which makes cancer cells more susceptible to therapeutic interventions while simultaneously protecting healthy cells. Eigen is creating a high-throughput discovery platform that integrates proprietary machine learning algorithms to identify novel drug classes and therapeutic approaches capable of altering a cell’s state to increase vulnerability to treatments. This platform combines biology and engineering, utilizing in-house developed robotic systems, laboratory operations software, and machine learning analysis pipelines. The company's mission focuses on improving patient outcomes by providing novel combination therapeutics that enhance efficacy and reduce toxicity in cancer care, ultimately aiming to meet significant medical needs in oncology.
Basil Systems
Seed Round in 2023
Basil Systems offers a SaaS analytics platform that uses machine learning to analyze product, market, and regulatory data for medical device and pharmaceutical companies. The platform provides AI-powered insights to inform product development, market strategy, and clinical decisions, helping clients access essential analytics that guide strategic choices, improve product and supply chain quality, mitigate recall risk, and shorten regulatory approval timelines, enabling the delivery of safe products.
Fabric Health
Seed Round in 2023
Fabric Health is a health technology company that improves family well-being by providing digital access to local healthcare resources. Its platform engages users during daily activities like laundry, allowing them to manage healthcare benefits, schedule appointments, and organize household services more efficiently.
Canid
Seed Round in 2023
Canid is a healthcare technology company that focuses on pediatric vaccination workflows. It provides a healthcare dashboard and process tool to simplify vaccination record management, automate vaccine workflow, and oversee vaccine inventory. The platform includes a scanning system that eliminates manual data entry by capturing vaccine information and uploading it to state immunization registries, reducing administrative tasks for pediatric practitioners. It also offers administrative consulting and helps secure vaccine margins, supporting efficient practice operations for clinicians while giving state officials clearer oversight of vaccination programs.
PulzAid
Pre Seed Round in 2023
PulzAid is a managed marketplace focused on providing healthcare services to injured workers. It facilitates access to telehealth, mobile imaging, specialists, and diagnostic services through its specialized software and established relationships with orthopedic surgeons and occupational medicine doctors. By offering on-demand video consultations, in-person nurse visits, lab testing, and prescription services, PulzAid aims to expedite the treatment process for employees, enabling them to return to work more quickly and in better health. The company's approach not only addresses workplace injuries but also seeks to reduce associated costs and liabilities for employers, particularly in managing workers' compensation claims.
Dentologie
Venture Round in 2023
Founded in 2013 by Dr. Hany Kurdi, Dentologie revolutionizes the dental experience by creating safe, inclusive spaces that combine compassionate care, clinical expertise, and innovative design. Headquartered in Chicago, Illinois, the company offers a comprehensive range of services including general dentistry, Invisalign treatment, oral surgery, and cosmetic dentistry.
Mending
Seed Round in 2023
Mending develops a health insurance platform that aims to provide affordable, comprehensive care by strengthening the relationship between patients and primary care providers. The platform supports primary care and mental health visits, features low deductibles, and connects users to a broad network of doctors and hospitals, helping individuals and small businesses receive timely, personalized healthcare at a low cost.
eddii
Seed Round in 2023
Eddii is a digital health platform designed to motivate individuals with diabetes to manage their condition more effectively. It offers a gamified mobile application featuring an engaging virtual character that encourages users to track and record their health data daily, providing weekly reports and rewards for healthy practices.
VenoStent
Series A in 2023
VenoStent develops bioabsorbable smart polymer wraps for vascular surgeries. Its flagship product, SelfWrap, is a perivascular wrap designed to reduce failures at the vein-artery junction in dialysis patients by promoting outward vein growth and providing custom-fit mechanical support. The company's technology acts as an external stent, reducing surgery time, infection risk, and wound reopening while improving vein usability and durability.
Ossium Health
Series C in 2023
Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.
Upside Health
Seed Round in 2023
Upside Health, Inc. is a healthcare technology company based in New York, founded in 2017, that focuses on chronic pain management through its innovative mobile application, Ouchie. This application provides patients with targeted educational content and rewards for achieving functional milestones, fostering a supportive community for individuals managing chronic pain. Upside Health's platform includes remote patient monitoring and engagement tools that enable clinicians to access valuable data, improving care outcomes while minimizing additional burdens on healthcare providers. By empowering both patients and clinicians, Upside Health aims to transform the assessment and treatment of chronic pain, ultimately enhancing the quality of care and reducing healthcare costs.
3X Genetics
Pre Seed Round in 2023
3X Genetics is a company focused on developing medical screening solutions aimed at identifying genetic disorders, particularly in infants and children. The company has created innovative technologies that allow for proactive screening of the population for conditions such as myotonic dystrophy and other trinucleotide repeat issues associated with progressive muscle weakness. By enabling healthcare professionals to detect these genetic disorders early, 3X Genetics plays a crucial role in preventing the birth of children affected by serious genetic diseases.
Betterleave
Seed Round in 2023
Betterleave is a digital health platform dedicated to providing personalized care for individuals navigating grief and loss. It offers a comprehensive bereavement benefits service that supports employees coping with the death of a loved one, including family members, friends, colleagues, pets, or pregnancy loss. The platform combines human guidance with advanced software to engage users effectively, connecting them to essential resources and ongoing support. Betterleave’s services include individual grief counseling, group support, and navigation assistance through the complexities of bereavement. By integrating with insurers and partnering with employers, Betterleave coordinates value-driven care that enhances outcomes, reduces costs, and improves the overall member experience throughout the bereavement process.
PharmaCCX
Seed Round in 2023
PharmaCCX is a healthcare technology company established in 2017, headquartered in Boston with additional offices in Stockholm, San Mateo, and Zug. It operates a platform that facilitates pricing negotiations and procurement processes between oncology pharmaceutical companies and healthcare payers, aiming to accelerate patient access to necessary medicines. The platform offers a configurable infrastructure for planning, negotiating, and managing deals, enabling market access teams at pharma companies and payers to efficiently administer innovative payment models.
ROOK
Seed Round in 2023
ROOK is an API-first company that connects applications and software with valuable health data and insights derived from users' wearable devices.
Adora Health
Seed Round in 2023
Adora Health is a digital health company focused on supporting women's health, particularly during menopause. It has developed an application that utilizes natural language processing and artificial intelligence to provide personalized health management solutions. The platform offers a range of tools, including telehealth services, tailored advice, and lifestyle recommendations, all aimed at helping women navigate their health and well-being during this significant life stage. By integrating technology with women's health needs, Adora Health empowers users to make informed decisions regarding their nutrition and overall wellness.
Oliva Health
Seed Round in 2023
Oliva Therapy is an online mental healthcare platform based in Barcelona, Spain, founded in 2020. It aims to make mental healthcare accessible, uncomplicated, and stigma-free for busy individuals. The platform allows users to book one-hour therapy sessions via real-time video calls with expert-curated therapists, who are matched to users based on their specific needs. By simplifying the process of seeking therapy, Oliva helps working professionals achieve their mental health goals while maintaining a better work-life balance. The focus on personalized matching and a hassle-free online experience distinguishes Oliva in the mental health sector.
Outbound AI
Seed Round in 2023
Outbound AI is a Seattle-based startup founded in 2021 that specializes in conversational AI tailored for the healthcare industry. The company focuses on automating and enhancing back-office administrative tasks within the revenue cycle, such as claim status inquiries, eligibility and benefits verification, explanation of benefits capture, and prior authorization processes. Outbound AI leverages advanced cloud technologies, including a real-time inference engine and cognitive capabilities, to improve productivity and the overall job experience for healthcare workers. The team comprises experienced professionals from health and voice technology sectors, driving innovation to achieve higher levels of accuracy, transparency, and trust in healthcare operations.
Forta
Series A in 2023
Forta provides healthcare services for children, specializing in autism support through applied behavior analysis therapy delivered via online training programs. It operates a telehealth platform offering AI-driven interventions and a personalized care approach that enables parents and caregivers to access structured guidance, expert support, and adaptive treatment plans designed to promote skill building and behavioral improvement.
AlliConnect
Seed Round in 2023
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%!
Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
Mend
Series A in 2023
MEND is a life sciences company dedicated to improving health outcomes through targeted clinical nutrition and medical food interventions. The company focuses on researching and developing products that aid in healing from injuries, surgeries, and illness, as well as enhancing physical performance and addressing the challenges of aging. MEND's innovations have gained acceptance in various sectors, including hospitals, health systems, professional sports teams across major leagues, and elite military forces in the United States. The company's commitment to ongoing research and development positions it as a key player in the field of clinical nutritional products, aimed at enabling caregivers to support patients in achieving optimal health and recovery.
Synteny.Ai
Seed Round in 2023
Synteny.Ai Syntney decodes the signals of immune repertoires to help biotech research and pharma companies with disease discoveries.
DropStat
Venture Round in 2023
DropStat is a technology company that offers an app-based platform designed to optimize staffing for hospitals. Founded in 2017 and headquartered in Beverly Hills, California, DropStat utilizes artificial intelligence and machine learning to predict and autonomously fill staffing gaps, allowing healthcare facilities to manage labor costs more effectively. By streamlining the process of calling staff for open shifts, the platform eliminates the need for traditional communication methods such as calls and texts, thereby enhancing efficiency and reducing financial waste. In addition to improving operational processes, DropStat prioritizes data security, ensuring that sensitive information is protected both in the system and during transmission. The company's mission is to modernize shift communication, ultimately aiming to enhance both patient and staff satisfaction.
Pathfinder Health
Seed Round in 2023
Pathfinder Health is a company that focuses on supporting the development of children aged 0-5 through an evidence-based clinical tool. This tool aids in monitoring child development milestones and offers guidance on how caregivers can effectively engage with children at various stages of their growth. By facilitating communication with healthcare professionals, the app promotes earlier diagnoses of developmental concerns. It also provides users with access to a wealth of resources, including evidence-based activities, articles, parenting tips, and local early intervention services. Through its innovative approach, Pathfinder Health empowers parents and caregivers to track their child's progress and identify potential developmental issues promptly.
Iolyx Therapeutics
Series A in 2023
Iolyx Therapeutics is a biotechnology company focused on ocular diseases, developing immunology-driven therapies for ophthalmology and advancing a platform for tailored formulations that enable precise local delivery of immunological drugs to ocular tissues, targeting inflammation at its source in both the anterior and posterior segments to improve efficacy, safety, and patient convenience.
Rensair
Series A in 2023
Rensair develops portable hospital-grade air purifiers designed for hospitals, schools and care homes, trusted by businesses worldwide. Its purification technology combines HEPA-grade filtration with ozone-free ultraviolet light to clean the air and reduce airborne contaminants, creating healthier indoor environments while aiming to lower emissions and energy use.
Work & Mother
Venture Round in 2023
Work & Mother provides lactation suites in commercial buildings and a supportive app for working mothers. These suites offer hospital-grade equipment, cleaning services, refrigeration, and additional resources via the app, helping employers meet legal obligations and promoting workplace wellbeing.
Andromeda Surgical
Seed Round in 2023
Andromeda Surgical develops autonomous robotic systems aimed at enhancing surgical precision, consistency, and efficiency.
Mign
Seed Round in 2023
Mign is a company focused on revolutionizing the design and production of personalized medical devices for musculoskeletal health. It specializes in developing digital solutions for orthopedic products, utilizing proprietary technology that synthesizes complex three-dimensional body data. This approach allows Mign to create custom wearables tailored to individual physical requirements, featuring breathable three-dimensional patterns that enhance comfort and functionality. By integrating advanced design tools and a commitment to sustainability, Mign aims to improve patient outcomes in orthopedic care through innovative and personalized solutions.
Jona
Seed Round in 2023
Jona is a tech startup utilizing artificial intelligence to explore the connection between the microbiome and health. Its platform interprets microbiome tests, providing insights into bacteria, fungi, viruses, and protists, along with associated health conditions, symptoms, food sensitivities, and recommended actions for diet, exercise, sleep, and treatments.
Mantra Health
Series A in 2023
Mantra Health is a digital mental healthcare provider specializing in university students. It offers integrated telemental health programs, improving clinical outcomes and reducing wait times for universities of all sizes.
Options MD
Seed Round in 2023
Options MD is a telemedicine platform that employs AI-driven algorithms to match individuals with severe or treatment-resistant mental illnesses to personalized care options. It then connects these patients with in-house psychiatric experts for appropriate medical assistance.
Bionic Health
Seed Round in 2023
Bionic Health specializes in digital healthcare, focusing on preventative health services for individuals with chronic pain. The company's platform offers frequent diagnostics and employs machine learning to create customized treatment plans, aiming to slow down aging and provide personalized insights for patients.
Womaness
Seed Round in 2023
Womaness develops innovative products tailored to women's health needs, focusing on menopausal symptoms. Their range includes supplements, sexual wellness items, and skincare products, all free from common irritants and formulated to support women during this life stage.
Dimension Inx
Series A in 2023
Dimension Inx designs and develops advanced biomaterials for regenerative medicine. Founded in 2017, it specializes in creating microenvironments that guide the body's natural healing processes. Its platform focuses on the interplay between material composition, microstructure, and microarchitecture to produce biofunctional materials.
Featureform
Seed Round in 2023
Featureform is a company that specializes in developing machine learning tools tailored for the pharmaceutical and biotechnology sectors. It offers an open-source virtual feature store that enables data scientists to define, manage, and serve machine learning features throughout their organizations. The platform provides a unified interface to connect, transform, and join both streaming and batch data, facilitating the discovery and integration of features created by various teams. This functionality allows organizations to share features and enhance their machine learning models. Additionally, Featureform monitors and analyzes these features, offering the capability to freeze them, which allows teams to concentrate on building models that support efficient data pipelines.
Precision Neuroscience
Series B in 2023
Precision Neuroscience is a New York-based neurotechnology company developing a next-generation brain–computer interface platform to enable breakthrough treatments for neurological illnesses affecting billions worldwide. The company aims to deliver minimally invasive, safely removable implants capable of processing large amounts of neural data across multiple brain regions to support therapeutic interventions. Founded in 2021, it focuses on translating neural signals into clinical outcomes, with technology described as a thin-film microelectrode array that conforms to the brain surface without penetrating tissue, enabling broad neural data collection to aid treatment of spinal cord injuries, stroke, and neurodegenerative diseases.
Gilgamesh Pharmaceuticals
Series B in 2022
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York, focused on developing innovative psychotropic drugs to address mental health issues. Founded in 2019, the company specializes in creating novel compounds that enhance the benefits of traditional psychedelics, improving parameters such as safety, tolerability, duration, and efficacy. Gilgamesh targets a range of neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. With the growing global mental health crisis, the company aims to accelerate the development of new treatments that meet the urgent need for effective solutions in mental health care, leveraging its expertise in medicinal chemistry and drug development.
Eigen Therapeutics
Seed Round in 2022
Eigen Therapeutics is a biotechnology company dedicated to advancing cancer treatment through the development of innovative therapies. It specializes in "priming" therapies that enhance the effectiveness of targeted treatments by addressing cancer heterogeneity, which makes cancer cells more susceptible to therapeutic interventions while simultaneously protecting healthy cells. Eigen is creating a high-throughput discovery platform that integrates proprietary machine learning algorithms to identify novel drug classes and therapeutic approaches capable of altering a cell’s state to increase vulnerability to treatments. This platform combines biology and engineering, utilizing in-house developed robotic systems, laboratory operations software, and machine learning analysis pipelines. The company's mission focuses on improving patient outcomes by providing novel combination therapeutics that enhance efficacy and reduce toxicity in cancer care, ultimately aiming to meet significant medical needs in oncology.
MedCrypt
Series B in 2022
Founded in 2016, MedCrypt specializes in cybersecurity software for medical devices. Its solutions ensure data security and protect against unauthorized access across a wide range of devices, from pacemakers to surgical robots.
SendaRide
Series B in 2022
SendaRide, Inc. is a transportation service provider focused on non-emergency medical transportation for patients, particularly the elderly and children. Founded in 2016 and headquartered in Oklahoma City, the company operates a platform that allows users to find and book both on-demand and pre-scheduled rides. SendaRide's application offers customized transportation solutions tailored to the healthcare industry, facilitating safe and reliable transport for users. Additionally, the platform includes features such as GPS monitoring and live video feeds, allowing users to track their drivers or caretakers during transit. Users can also rate their experiences, enhancing service accountability and quality.
Surge Therapeutics
Series A in 2022
SURGE Therapeutics is a biotechnology company focused on enhancing cancer treatment outcomes through innovative immunotherapy solutions. It has developed a proprietary injectable biodegradable hydrogel designed to deliver cancer therapeutics in a prolonged and localized manner. This technology enables targeted release of immunotherapy agents at the surgical site following tumor resection, allowing for more effective treatment administration. By optimizing the timing and location of drug delivery, SURGE Therapeutics aims to improve patient survival rates and minimize systemic side effects, representing a significant advancement in the field of cancer care.
Brave Health
Series C in 2022
Brave Health is a virtual clinic that provides telehealth services focused on mental health and addiction treatment. Established in 2017 by Anna Lindow in Miami, Florida, the company specializes in behavioral health, offering a range of services including counseling, therapy, psychiatry, and medication management. This includes medication-assisted treatment, allowing patients to receive comprehensive care for various conditions related to mental health and substance use disorders. By leveraging telehealth technology, Brave Health enables patients to access essential services conveniently and efficiently, addressing the growing need for accessible mental health care.
Remedial Health
Seed Round in 2022
Remedial Health is a company focused on enhancing the procurement and distribution of pharmaceuticals across Africa. It provides a platform that facilitates business-to-business access to medicines, enabling pharmacies and hospitals to order and access retail medications directly from manufacturers or distributors. This approach addresses the inefficiencies and risks associated with relying on open-air medicine markets, where healthcare providers often encounter counterfeit products. By improving the pharmacy operations and workflow management processes, Remedial Health aims to ensure that healthcare providers can more effectively stock their facilities, thereby contributing to a safer and more reliable healthcare environment.
Scratch
Series C in 2022
Scratch is a fintech company specializing in payment processing, patient financing, and communication tools for veterinary and medical practices. Approximately half of U.S. veterinary clinics use its platform to interact with clients and facilitate transactions.
Kalderos
Venture Round in 2022
Kalderos, Inc. is a healthcare technology company that specializes in drug discount management solutions. Founded in 2016 and headquartered in Chicago, Illinois, with an additional location in Brookfield, Wisconsin, Kalderos offers a software-as-a-service (SaaS) platform designed to analyze and optimize the coordination of drug discount programs for healthcare providers, manufacturers, and payers. The platform employs advanced models and machine learning processes to identify and resolve non-compliance issues, detect inconsistencies, and provide data management capabilities. By offering features such as claims verification, dispute resolution, and discount monitoring, Kalderos enables its clients to streamline the communication and payment processes associated with drug discounts, ultimately eliminating waste and enhancing efficiency in the healthcare system.
Fabric Health
Seed Round in 2022
Fabric Health is a health technology company that improves family well-being by providing digital access to local healthcare resources. Its platform engages users during daily activities like laundry, allowing them to manage healthcare benefits, schedule appointments, and organize household services more efficiently.
Abingdon Software Group
Seed Round in 2022
Abingdon Software Group develops mission-critical enterprise platforms that support digital transformation in various industries. Their platform offers systems of record and automation features such as patient records management, workforce scheduling, fiber network mapping, and document lifecycle tools, enabling organizations to modernize operations and improve data management across sectors like logistics, healthcare, telecommunications, and government.
Health Note
Series A in 2022
Health Note is an AI-powered health data management platform that collects patient information through voice and digital intake tools, automatically formats it into clinical notes, and integrates with electronic medical records to streamline documentation and pre-visit workflows. The platform is frictionless and platform-agnostic, enabling patients to participate in their care without apps or portals and reducing administrative burden for clinicians while improving care team efficiency. Founded in 2018 and based in San Francisco, Health Note aims to simplify clinical documentation and EMR integration.
Moving Analytics
Series A in 2022
Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.
Sesame
Series B in 2022
Sesame, Inc., operating as SesameCare, is a healthcare technology company founded in 2018 and based in New York, New York. The company has developed an innovative platform that enables users to book medical appointments and access healthcare services conveniently and affordably. By leveraging an AI-enabled marketplace, SesameCare eliminates the need for health insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. This approach allows the company to offer Americans high-quality medical care at significantly reduced costs. Additionally, Sesame is recognized as the official telehealth partner of Costco, further enhancing its reach and service offerings.
Boulder Care
Series B in 2022
Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.
Quadrant Health
Pre Seed Round in 2022
Quadrant Health is a health technology company that provides a cloud-based analytics platform for healthcare providers to analyze electronic health records and patient messaging data in real time. The platform uses machine learning to identify potential health risks and to predict infections, injuries, and other harms before symptoms appear, enabling proactive patient care and support for preventive medicine.
Miga
Seed Round in 2022
Miga is a virtual cardiometabolic clinic offering a gamified mobile app for managing obesity, hypertension, diabetes, and hyperlipidemia. It combines clinical services such as labs, devices, pharmacy, and lifestyle coaching.
NeuraLight
Series A in 2022
NeuraLight is a venture-backed company dedicated to improving the lives of billions affected by neurological disorders. It develops a digital neurology platform that uses smartphone or webcam technology to accurately assess and monitor patients, enabling better evaluation and care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.